Factors governing the affinity and selectivity of histone deacetylase inhibitors for the HDAC8 enzyme active site: Implications for anticancer therapy. (19th July 2021)
- Record Type:
- Journal Article
- Title:
- Factors governing the affinity and selectivity of histone deacetylase inhibitors for the HDAC8 enzyme active site: Implications for anticancer therapy. (19th July 2021)
- Main Title:
- Factors governing the affinity and selectivity of histone deacetylase inhibitors for the HDAC8 enzyme active site: Implications for anticancer therapy
- Authors:
- Toshev, Nikolay
Cheshmedzhieva, Diana
Dudev, Todor - Abstract:
- Abstract: Disruptions in post‐translational modifications of chromatin structure promote uncontrollable cell growth branded as a hallmark of tumor lesions. The overexpression/hyperactivity of histone deacetylases (HDACs) is a common feature for the tumorogenesis and cancer progression. Several inhibitors of histone deacetylases (mainly hydroxamic acid derivatives) have been successfully used as drugs in fighting tumor formations. However, there is no systematic study on the factors controlling the affinity and selectivity of this type of inhibitors to the host enzyme thus hampering successful rational design of more potent and selective anticancer drugs. Herein, in an attempt to unravel the mechanism of the host–guest interactions in these systems at atomic level, we systematically study the effect of various factors in the process and elucidate its key determinants. Density functional theory calculations have been employed. Our findings have the potential to be employed as guidelines in designing new HDAC inhibitors with improved anticancer properties. Abstract : Density functional calculations on complexes between a series of inhibitors and HDAC8 active site have been employed in unraveling the key factors governing the affinity and selectivity of the host enzyme for the guest substances. The findings could serve as guidelines in designing new HDAC8 inhibitors with improved anticancer properties.
- Is Part Of:
- Journal of physical organic chemistry. Volume 34:Number 12(2021)
- Journal:
- Journal of physical organic chemistry
- Issue:
- Volume 34:Number 12(2021)
- Issue Display:
- Volume 34, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 34
- Issue:
- 12
- Issue Sort Value:
- 2021-0034-0012-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-07-19
- Subjects:
- anticancer therapy -- DFT -- HDAC8 -- histone deacetylase inhibitors -- molecular modeling
Chemistry, Physical organic -- Periodicals
547.1 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/poc.4268 ↗
- Languages:
- English
- ISSNs:
- 0894-3230
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5036.211000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19838.xml